2015 Non Alcoholic Fatty Liver Disease (NAFLD) Market Clinical Trials Review Across The Globe

1
Non Alcoholic Fatty Liver Disease (NAFLD) Global
Clinical Trials Review, H1, 2015 www.bigmarketres
earch.com
2
Report Description
GlobalData's clinical trial report, "Non
Alcoholic Fatty Liver Disease (NAFLD) Global
Clinical Trials Review, H1, 2015" provides data
on the Non Alcoholic Fatty Liver Disease (NAFLD)
clinical trial scenario. This report provides
elemental information and data relating to the
clinical trials on Non Alcoholic Fatty Liver
Disease (NAFLD). It includes an overview of the
trial numbers and their recruitment status as per
the site of trial conduction across the globe.
The databook offers a preliminary coverage of
disease clinical trials by their phase, trial
status, prominence of the sponsors and also
provides briefing pertaining to the number of
trials for the key drugs for treating Non
Alcoholic Fatty Liver Disease (NAFLD). This
report is built using data and information
sourced from proprietary databases, primary and
secondary research and in-house analysis by
GlobalData's team of industry experts. Read
complete report here _at_ http//www.bigmarketresea
rch.com/non-alcoholic-fatty-liver-disease-nafld-gl
obal-clinical-trials-review-h1-2015-market
3
Report Description

• Scope
• Data on the number of clinical trials conducted
  in North America, South and Central America,
  Europe, Middle-East and Africa and Asia-pacific
  and top five national contributions in each
• Clinical trial (complete and in progress) data by
  phase, trial status, subjects recruited and
  sponsor type
• Listings of discontinued trials (suspended,
  withdrawn and terminated)
• Get enquire about report here _at_
• http//www.bigmarketresearch.com/report-enquiry/17
  8081

4
Table Of Contents

• Introduction
• Non Alcoholic Fatty Liver Disease (NAFLD)
• Report Guidance
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical
  Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical
  Trials in Europe
• Top Countries Contributing to Clinical Trials in
  North America
• Top Countries Contributing to Clinical Trials in
  Middle East and Africa
• Top Countries Contributing to Clinical Trials in
  Central and South America
• Clinical Trials by G7 Countries Proportion of
  Non Alcoholic Fatty Liver Disease (NAFLD) to
  Gastrointestinal Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries Proportion of
  Non Alcoholic Fatty Liver Disease (NAFLD) to
  Gastrointestinal Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status

5
Table Of Contents

• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Unaccomplished Trials of Non Alcoholic Fatty
  Liver Disease (NAFLD)
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Non Alcoholic
  Fatty Liver Disease (NAFLD) Therapeutics
• Clinical Trials
• Prominent Drugs
• Clinical Trial Profiles
• Clinical Trial Overview of Top Companies
• Galmed International Ltd.
• Clinical Trial Overview of Galmed International
  Ltd.
• AstraZeneca PLC
• Clinical Trial Overview of AstraZeneca PLC
• TCM Biotech International Corp
• Clinical Trial Overview of TCM Biotech
  International Corp

6
Table Of Contents

• Phenex Pharmaceuticals AG
• Clinical Trial Overview of Phenex Pharmaceuticals
  AG
• PharmaKing Co., Ltd.
• Clinical Trial Overview of PharmaKing Co., Ltd.
• Genextra S.p.a.
• Clinical Trial Overview of Genextra S.p.a.
• F. Hoffmann-La Roche Ltd.
• Clinical Trial Overview of F. Hoffmann-La Roche
  Ltd.
• Barij essence Company
• Clinical Trial Overview of Barij essence Company
• Antipodean Pharmaceuticals, Inc.
• Clinical Trial Overview of Antipodean
  Pharmaceuticals, Inc.
• Abbott Laboratories
• Clinical Trial Overview of Abbott Laboratories
• Clinical Trial Overview of Top Institutes /
  Government
• Tabriz University of Medical Sciences
• Clinical Trial Overview of Tabriz University of
  Medical Sciences
• Third Military Medical University

7
Table Of Contents

• Clinical Trial Overview of Third Military Medical
  University
• Tehran University of Medical Sciences
• Clinical Trial Overview of Tehran University of
  Medical Sciences
• University of Michigan
• Clinical Trial Overview of University of Michigan
  
• The National Institute of Diabetes and Digestive
  and Kidney Diseases
• Clinical Trial Overview of The National Institute
  of Diabetes and Digestive and Kidney Diseases
• FUDAN University
• Clinical Trial Overview of FUDAN University
• Massachusetts General Hospital
• Clinical Trial Overview of Massachusetts General
  Hospital
• Chinese University of Hong Kong
• Clinical Trial Overview of Chinese University of
  Hong Kong
• Ahvaz Jundishapur University of Medical Sciences
• Clinical Trial Overview of Ahvaz Jundishapur
  University of Medical Sciences
• Bambino Gesu Hospital and Research Institute
• Clinical Trial Overview of Bambino Gesu Hospital
  and Research Institute

8
Report Description

• Reasons to buy
• Understand the dynamics of a particular
  indication in a condensed manner
• Abridged view of the performance of the trials in
  terms of their status, recruitment, location,
  sponsor type and many more
• Obtain discontinued trial listing for trials
  across the globe
• Espy the commercial landscape of the major
  Universities / Institutes / Hospitals or
  Companies

9
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/non-alcoholic-fat
ty-liver-disease-nafld-global-clinical-trials-revi
ew-h1-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com